Book contents
- 50 Big Debates in Reproductive Medicine
- Series page
- 50 Big Debates in Reproductive Medicine
- Copyright page
- Contents
- Contributors
- Foreword
- Introduction
- Section I Limits for IVF
- Section II IVF Add-ons
- Section III The Best Policy
- Section IV Embryology
- Section V Ethics and Statistics
- 30A Sex Selection Should Be Permitted for Family Balancing
- 30B Sex Selection Should Be Permitted for Family Balancing
- 31A Reproductive Medicine Should Be Publicly Funded
- 31B Reproductive Medicine Should Be Publicly Funded
- 32A Gamete Donation Should Be Anonymous
- 32B Gamete Donation Should Be Anonymous
- 33A Uterus Transplantation Is a Step Too Far
- 33B Uterus Transplantation Is a Step Too Far
- 34A Meta-analysis Should Not Be Considered Class A Evidence
- 34B Meta-analysis Should Not Be Considered Class A Evidence
- Section VI Male-factor Infertility
- Section VII Genetics
- Section VIII Ovarian Stimulation
- Section IX Hormones and the Environment
- Index
- References
32B - Gamete Donation Should Be Anonymous
Against
from Section V - Ethics and Statistics
Published online by Cambridge University Press: 25 November 2021
By
Book contents
- 50 Big Debates in Reproductive Medicine
- Series page
- 50 Big Debates in Reproductive Medicine
- Copyright page
- Contents
- Contributors
- Foreword
- Introduction
- Section I Limits for IVF
- Section II IVF Add-ons
- Section III The Best Policy
- Section IV Embryology
- Section V Ethics and Statistics
- 30A Sex Selection Should Be Permitted for Family Balancing
- 30B Sex Selection Should Be Permitted for Family Balancing
- 31A Reproductive Medicine Should Be Publicly Funded
- 31B Reproductive Medicine Should Be Publicly Funded
- 32A Gamete Donation Should Be Anonymous
- 32B Gamete Donation Should Be Anonymous
- 33A Uterus Transplantation Is a Step Too Far
- 33B Uterus Transplantation Is a Step Too Far
- 34A Meta-analysis Should Not Be Considered Class A Evidence
- 34B Meta-analysis Should Not Be Considered Class A Evidence
- Section VI Male-factor Infertility
- Section VII Genetics
- Section VIII Ovarian Stimulation
- Section IX Hormones and the Environment
- Index
- References
Summary
Third-party reproduction is a significant proportion of the undertakings of most reproductive medicine clinics and practitioners. One of the most prominent concerns is the issue of anonymity of the gamete donor. This issue potentially impacts the intended parent(s), the donor and the donor-conceived child. Disclosure of a gamete donor carries less risk of harm to the donor-conceived child than non-disclosure. Whether the child is informed or not by the parent, in time, that older child/adult will discover there is an inconsistency in their genetic origins. How will you as the parent then answer those very awkward questions?
- Type
- Chapter
- Information
- 50 Big Debates in Reproductive Medicine , pp. 167 - 168Publisher: Cambridge University PressPrint publication year: 2021
References
Further Reading
Golombok, S. Disclosure and donor-conceived children. Hum Reprod. 2017;32:1532–3.CrossRefGoogle ScholarPubMed
Harper, JC, Kennett, D, Reisel, D. The end of donor anonymity: how genetic testing is likely to drive anonymous gamete donation out of business. Hum Reprod. 2016;31:1135–40.CrossRefGoogle ScholarPubMed
Illioi, E, Blake, L, Jadva, V, Roman, G, Golombok, S. The role of age of disclosure of biological origins in the psychological wellbeing of adolescents conceived by reproductive donation: a longitudinal study from age 1 to age 14. J Child Psychol Psychiatr. 2017;58:315–34.Google Scholar
Pennings, G. Disclosure of donor conception, age of disclosure and the well-being of donor offspring. Hum Reprod. 2017;32:969–73.CrossRefGoogle ScholarPubMed
Skoog Svanberg, A, Sydsjo, G, Lampic, C. Psychosocial aspects of identity-release gamete donation – perspectives of donors, recipients, and offspring. Upsala J Med Sci. 2019, Online https://doi.org/10.1080/03009734.2019.1696431.CrossRefGoogle Scholar